# CORRESP — Quoin Pharmaceuticals, Ltd.  (QNRX)  (CIK 0001671502)

> <strong>Quoin Pharmaceuticals, Ltd.  (QNRX)  (CIK 0001671502) → SEC staff</strong> · filed 2025-12-02 · ticker QNRX · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-25-117689
- **Form:** CORRESP
- **Filer:** Quoin Pharmaceuticals, Ltd.  (QNRX)  (CIK 0001671502)
- **CIK:** 0001671502
- **Ticker:** QNRX
- **Filed:** 2025-12-02
- **SIC industry:** 2834
- **HQ:** Kfar Saba

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1671502/000110465925117689/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1671502&type=UPLOAD&dateb=&owner=include&count=40

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, Quoin Pharmaceuticals, Ltd.  (QNRX)  (CIK 0001671502) (CIK 0001671502), filed 2025-12-02, accession 0001104659-25-117689. Retrieved via MORVS 2026-11-13 from https://api.morvs.ai/comment-letter/0001104659-25-117689.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*